AstraZeneca (AZNL)

14,030.00p
   
  • Change Today:
    -2.62p
  • 52 Week High: 14,408.00
  • 52 Week Low: 9,642.00
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 416,937
  • Market Cap: £177,362m

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.
Brands: Losec, Prilosec, Nexium, Crestor

Key Personnel

Senior Independent Non-Executive Director: Philip A J Broadley
CEO and Executive director: Pascal Soriot
CFO & Executive Director: Aradhana Sarin
Chairman: Michel Demare
Independent Non-Executive Director: Nazneen Rahman
Independent Non-Executive Director: Euan Ashley
Independent Non-Executive Director: Sheri McCoy
Independent Non-Executive Director: Diana Layfield
Independent Non-Executive Director: Tony Mok
Non-Executive Dir: Marcus Wallenberg, Karen Knudsen, Anna Manz, Rene Haas, Birgit Conix

Contact Details

Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge,United Kingdom, CB2 0AA
Phone: +44 (0)20 3749 5000
Fax: +44 (0)20 7604 8151
Website: http://www.astrazeneca.com

Listings

Overseas Listings: LSE:AZN
ISIN: GB0009895292

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 14,030.00p
Change Today -2.62p
% Change -1.83 %
52 Week High 14,408.00
52 Week Low 9,642.00
Volume 416,937
Shares Issued 1,264.16m
Market Cap £177,362m

Trades for 15-Jan-2026

Time Volume / Share Price
16:29 34 @ 14,030.00p
16:29 20 @ 14,028.00p
16:29 31 @ 14,026.00p
16:29 67 @ 14,030.00p
16:29 29 @ 14,028.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page